Study search
Go straight to the source
Search PubMed, Europe PMC and ClinicalTrials.gov from one box. Results come from the indexes themselves, newest first, each linked to its original record.
Amiravo's reviewed summary: Afamelanotide research reference →
104 records · showing 25 · open this search in PubMed
- PubMedAcute impact of afamelanotide on UVR erythemal and melanogenic responses in healthy humans in vivo: an exploratory study.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026 Sep 1
- PubMedClinical TrialLetterAdjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study.Photochemistry and photobiology · 2026 Sep-Oct
- PubMedResearch Support, Non-U.S. Gov'tResearch Support, N.I.H., ExtramuralHeterochiral co-assembly of β-strands and hairpins affords stereocomplexed peptide hydrogels for drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2026 Jul 10
- PubMedReviewA Review of Randomized Controlled Trials for Vitiligo Therapies Published Between 2013 and 2023.Cureus · 2026 Jul
- PubMedInvestigation of the stability profile of therapeutic α-MSH analogue: Insights from liquid chromatography-high resolution mass spectrometry analysis of afamelanotide.Journal of pharmaceutical and biomedical analysis · 2026 May 15
- PubMedAfamelanotide improves quality of life and light tolerance in Austrian erythropoietic protoporphyria patients.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026 Mar 6
- PubMedReviewNew and currently investigated pharmacotherapies for the erythropoietic protoporphyrias: spotlight on dersimelagon and bitopertin.Expert opinion on pharmacotherapy · 2026 Mar
- PubMedCase ReportsCongenital Erythropoietic Porphyria with Persistent Severe Biochemical Abnormalities and a Non-Mutilating Clinical Course: A Case Report.Reports (MDPI) · 2026 Feb 16
- PubMedCase ReportsFrom darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria.JAAD case reports · 2026 Feb
- PubMedEnglish AbstractReview[Hormones and skin pigmentation: fundamentals and clinical relevance].Dermatologie (Heidelberg, Germany) · 2026 Jan
- PubMedNew pharmacotherapies for the erythropoietic protoporphyrias: an analysis of trial protocols from a patient perspective.Orphanet journal of rare diseases · 2025 Dec 29
- PubMedLetterLetter to the Editor - Qualitative evidence submitted by patients to NICE: need for more quality or unrealistic and unfair requirements?Journal of comparative effectiveness research · 2025 Dec
- PubMedBurden of illness and unmet needs in patients with erythropoietic protoporphyria and X-linked protoporphyria: A large US nationwide claims analysis.Journal of managed care & specialty pharmacy · 2025 Dec
- PubMedAfamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective.Clinical and experimental dermatology · 2025 Oct 27
- PubMedReviewPolymorphism of Melanocortin Receptor Genes-Association with Inflammatory Traits and Diseases.Diseases (Basel, Switzerland) · 2025 Sep 16
- PubMedSilica-Assisted Solid-Phase Peptide Synthesis (SiPPS).Journal of peptide science : an official publication of the European Peptide Society · 2025 Sep
- PubMedReviewCase ReportsErythropoietic protoporphyria in childhood: clinical clues, missed diagnoses and emerging therapy.European journal of pediatrics · 2025 Aug 27
- PubMedThe Impact of Minimal Sunlight Exposure on Bone Health: Insights From a Cohort Study in Erythropoietic Protoporphyria.The Journal of clinical endocrinology and metabolism · 2025 May 19
- PubMedObservational StudyMulticenter StudyGerman Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP).Photodermatology, photoimmunology & photomedicine · 2025 Mar
- PubMedReviewTreatment Advances in Vitiligo: An Updated Review.Dermatology practical & conceptual · 2025 Jan 30
- PubMedReviewResearch Support, Non-U.S. Gov'tErythropoietic protoporphyrias: Pathogenesis, diagnosis and management.Liver international : official journal of the International Association for the Study of the Liver · 2025 Jan
- PubMedDiscovery of MT-7117 (Dersimelagon Phosphoric Acid): A Novel, Potent, Selective, and Nonpeptidic Orally Available Melanocortin 1 Receptor Agonist.Journal of medicinal chemistry · 2024 Dec 26
- PubMedMechanistic Model for Drug Release from PLGA-Based Biodegradable Implants for In Vitro Release Testing: Development and Validation.ACS applied bio materials · 2024 Nov 18
- PubMedEditorialCommentVitamin D status in patients with erythropoietic protoporphyria taking the systemic photoprotective agent afamelanotide.The British journal of dermatology · 2024 Aug 14
- PubMedMulticenter StudyObservational StudyThe effects of cholecalciferol and afamelanotide on vitamin D levels in erythropoietic protoporphyria: a multicentre cohort study.The British journal of dermatology · 2024 Aug 14
Queries go directly from your browser to NCBI, EMBL-EBI and ClinicalTrials.gov; Amiravo does not store them. Study-type labels come from the indexes and can be wrong. A record's presence says nothing about whether a compound works or is safe. PubMed data via NCBI E-utilities; see NCBI policies.